Skip to content
Screener

EPS (Diluted) at other companies

IAR
Integra LifeSciencesIART
$0.06+101%
MiMedx Group logo
MiMedx GroupMDXG
-$0.10-267%
Organogenesis Holdings Inc. logo
Organogenesis Holdings Inc.ORGO
-$0.77-670%
Solventum logo
SolventumSOLV
$0.53+3.9%
InfuSystem Holdings logo
InfuSystem HoldingsINFU
$0.05+600%
ClearPoint Neuro logo
ClearPoint NeuroCLPT
-$0.32-45.5%

Other financials

Income statement

See full
Revenue$9.7M-3.1%
Gross profit$7.4M-5.4%
Operating income-$280.0K-119%
Net income-$676.0K-223%

Balance sheet

See full
Cash & equivalents$9.4M+10.4%
Total debt$14.5M+1,123%
Total equity$2.8M+115%
Total assets$36.6M+10.8%

Cash flow

See full
Operating cash flow$425.0K-57.2%
CapEx$334.0K-71.2%
Free cash flow$91.0K+155%

Valuation

See full
Market cap$41.89M-46.4%
Enterprise value$46.97M
P/E2.7×
P/S

Profitability

See full
Gross margin76.3%-1.3pp
Operating margin3.4%-10.8pp
Net margin34.9%+20.0pp
FCF margin9.6%+9.4pp

Returns & leverage

See full
Return on equity-191.7%
Debt / equity5.2×
Current ratio1.3×+0.9×

Where this comes from

Reported directly by SANUWAVE Health, Inc. in its filing.

Tagged under the XBRL concept us-gaap:EarningsPerShareDiluted.

The source filing: SANUWAVE Health, Inc.’s 10-Q, filed August 6, 2026.

Filed
Aug 6, 2026, 4:37 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001628280-26-054393
Line itemThree Months Ended June 30,Six Months Ended June 30,
Income tax expense--
Net (Loss) Income$$551$$(5,567)
(Loss) Earnings per Share:
Basic$$0.06$$(0.65)
Diluted$$(0.04)$$(0.65)
Weighted average shares outstanding
Basic8,561,7378,554,706
Diluted9,167,8468,554,706

Item 1. Financial Statements (Unaudited)

FAQ

What is SANUWAVE Health, Inc.'s EPS (diluted)?
SANUWAVE Health, Inc. (SNWV) reported EPS (diluted) of -$0.08 in Q2 2026.
How has SANUWAVE Health, Inc.'s EPS (diluted) changed year-over-year?
SANUWAVE Health, Inc.'s EPS (diluted) decreased by 100.0% year-over-year, from -$0.04 to -$0.08.
What is the long-term trend for SANUWAVE Health, Inc.'s EPS (diluted)?
Over 4 years (2021 to 2025), SANUWAVE Health, Inc.'s EPS (diluted) has grown at a 35.8% compound annual growth rate (CAGR), from -$0.05 to -$0.17.
What does EPS (diluted) mean?
Net income divided by the weighted-average number of shares outstanding plus all potentially dilutive securities (stock options, convertibles, warrants). The most conservative EPS measure.

Ask your AI about SANUWAVE Health, Inc.'s eps (diluted).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude